Veradermics Shares Rise on Positive Hair Loss Drug Data
Shares of Veradermics (MANE) increased by approximately 16% after the company released positive top-line data from a Phase 2 study for its lead asset, VDPHL01. The results validated the design of an upcoming registrational trial expected to provide further insights.
